Follows people with early spondyloarthritis and related conditions in Germany over time
Follows people with early spine-related arthritis and linked conditions over several years.
Key facts
- Who runs it
- Charite University, Berlin, Germany
- Where
- Berlin, GermanySee the site
- Trial code
- Registry title
- German Spondyloarthritis Inception Cohort
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- Jul 2000
- Expected to end
- Jul 2030
- Type of study
- Observational, 6 groups
- Record updated
- 12 October 2021
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with a definite diagnosis of axial spondyloarthritis, juvenile spondyloarthritis, Crohn's disease, acute anterior uveitis, or psoriatic arthritis with axial involvement.
- Sex
- All sexes can join.
- Disease stage
- A definite diagnosis of axial spondyloarthritis or juvenile spondyloarthritis, Crohn's disease, acute anterior uveitis, or psoriatic arthritis with axial involvement.
The registry criteria, word for word
Show all 5 criteriaShow less
Other criteria
- Main inclusion Criteria:
- Patients with definite diagnosis of axial spondyloarthritis or juvenile spondyloarthritis
- Patients with definite diagnosis of Crohn's disease
- Patients with definite diagnosis of acute anterior uveitis
- Patients with definite diagnosis of psoriatic arthritis with axial involvement
Where in Germany
- Charité Universitätsmedizin BerlinBerlin, GermanyContact: Claudia LorenzTaking people
About the trial
What the trial wants to find out
The German Spondyloarthritis Inception cohort (GESPIC) was started 2000 as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA including ankylosing spondylitis (AS, also known as radiographic axial spondyloarthritis) and non-radiographic axial SpA. The objectives of GESPIC are to learn about the course of SpA during the very early stage of the disease, to appropriately assess the outcome including radiographic progression of patients after several years of follow-up, to identify outcome predictors, to assess quality of life, function, and costs (direct and indirect costs). GESPIC has been recently expanded to recruit patients with other forms of SpA / conditions associated with SpA: acute anterior uveitis, Crohn's disease as well as with psoriasis / axial psoriatic arthritis.
The 6 groups in the trial
- Ankylosing spondylitis
Ankylosing spondylitis according to the modified New York criteria or with the clinical diagnosis of AS/r-axSpA fulfilling the ASAS Classification Criteria AND the mNY criteria plus having the indiaction for starting a bDMARD therapy according to the treating rheumatologist
- Non-radiographic axial spondyloarthritis
Patients with clinical characteristics of axial SpA but not fulfilling the modified New York criteria for which radiographic sacroiliitis is essential or with the clinical diagnosis of nr-axSpA fulfilling the ASAS Classification Criteria not fulfilling the mNY criteria and the indiaction for starting a bDMARD therapy according to the treating rheumatologist
- Juvenile spondyloarthritis
Patients with juvenile spondyloarthritis (juvenile ankylosing spondylitis, juvenile non-AS-spondyloarthritis).
- Crohn's disease
Patients with Crohn's disease
- Acute anterior uveitis
Patients with acute anterior uveitis
- Axial psoriatic arthritis
Patients with the clinical diagnosis of psoriatic arthritis with axial involvement (sacroiliac joints and/or spine) (axPsA)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- German Spondyloarthritis Inception Cohort
- Plain-language title
- Follows people with early spondyloarthritis and related conditions in Germany over timeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 12 October 2021